May 2015

NeuroMetrix Prices Public Offering of $14.7 Million of Convertible Preferred … – Business Wire (press release)

NeuroMetrix Prices Public Offering of $14.7 Million of Convertible Preferred …Business Wire (press release)Subject to certain ownership limitations, the Series B convertible preferred stock is convertible at any time into an aggregate of 14,553,000 shares of common stock at a conversion price of $1.0101 per share and the warrants are exercisable for an … and […]

NeuroMetrix Prices Public Offering of $14.7 Million of Convertible Preferred … – Business Wire (press release) Read More »

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of … – Virtual-Strategy Magazine (press release)

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of …Virtual-Strategy Magazine (press release)On August 20, 2014, in addition to other securities, Cellectar issued 3,833,333 warrants to purchase shares of our common stock at an exercise price of $4.68 per share as part of an underwritten offering. In connection with the election to participate … and

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of … – Virtual-Strategy Magazine (press release) Read More »

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of … – GlobeNewswire (press release)

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of …GlobeNewswire (press release)On August 20, 2014, in addition to other securities, Cellectar issued 3,833,333 warrants to purchase shares of our common stock at an exercise price of $4.68 per share as part of an underwritten offering. In connection with the election to participate … and more

Cellectar Biosciences Announces Intent to Adjourn Annual Meeting Of … – GlobeNewswire (press release) Read More »

A Close Look at MABVAX THERAPEUTICS (OTCMKTS:MBVX) – MicroCap Daily

A Close Look at MABVAX THERAPEUTICS (OTCMKTS:MBVX)MicroCap DailyEach Unit consists of one share of common stock and a 30-month warrant to purchase one-half of one share of common stock (the “Warrant”). The Warrants are exercisable at $1.50 per each whole share of common stock. Laidlaw & Company (UK) Ltd. acted … …read more

A Close Look at MABVAX THERAPEUTICS (OTCMKTS:MBVX) – MicroCap Daily Read More »

Everyone Loves Stevia First Corp (OTCMKTS:STVF) – MicroCap Daily

Everyone Loves Stevia First Corp (OTCMKTS:STVF)MicroCap DailyIn addition, the Company issued to the investors three series of warrants to purchase additional shares of common stock. The financing was received and closed on May 11, 2015, and the full details of the transaction are available in the Company’s …Stevia First Corp. Closes $1.5 Million Private Placement

Everyone Loves Stevia First Corp (OTCMKTS:STVF) – MicroCap Daily Read More »

Form 4 Bankwell Financial Group For: May 21 Filed by: Fieber James A – StreetInsider.com

Form 4 Bankwell Financial Group For: May 21 Filed by: Fieber James AStreetInsider.comEach Unit consists of one share of Common Stock and an attached Warrant which gives the Reporting Person the right to purchase .3221 shares of the Company’s Common Stock at $14.00 per share once exercised. The exercise period for the Warrants is …

Form 4 Bankwell Financial Group For: May 21 Filed by: Fieber James A – StreetInsider.com Read More »

Asterias Biotherapeutics Receives $11.7M in Proceeds from Exercise of Warrants – Benzinga

Asterias Biotherapeutics Receives $11.7M in Proceeds from Exercise of WarrantsBenzingaAsterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that all outstanding common share purchase warrants originally issued in June 2014 were exercised prior to … and more …read more

Asterias Biotherapeutics Receives $11.7M in Proceeds from Exercise of Warrants – Benzinga Read More »

Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of … – MarketWatch

Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of …MarketWatchMENLO PARK, Calif., May 26, 2015 /PRNewswire/ — Asterias Biotherapeutics, Inc. (nyse mkt:AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that all outstanding common share purchase warrants … and more …read more

Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of … – MarketWatch Read More »

error: Content is protected !!
Scroll to Top